WHO expanded recommendation for Vekluryᆴ (Remdesivir) to patients with severe disease in update to COVID-19 guideline
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organizationメs Therapeutics and COVID-19: living guideline,…